Adverse Events Were Reported During The Clinical Trial, And Frequency
Russian adenovirus vector-based vaccine candidates include virus-like particles, and recombinant protein-based vaccines. Gamaleya Research Center received an international patent for Ebola vaccine. The vaccine, which consists of live-attenuated recombinant vesicular stomatitis virus (VSV) and recombinant adenovirus type-5 (Ad5) expressing Ebola…